S H Francis|I V Turko|J D Corbin - JoVE Visualize

Showing results (1-10 of 133) with videos related to

Pageof 14

Sort By:

The Biochemical Journal|March 7, 1998

Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylationI V Turko, S H Francis, J D Corbin

Biochemistry|May 2, 1998

Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivityI V Turko, S H Francis, J D Corbin

The Journal of Biological Chemistry|April 16, 1998

Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesteraseI V Turko, S H Francis, J D Corbin

Progress in Nucleic Acid Research and Molecular Biology|September 29, 2000

Cyclic nucleotide phosphodiesterases: relating structure and functionS H Francis, I V Turko, J D Corbin

European Journal of Biochemistry|April 28, 2000

Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activitiesJ D Corbin, I V Turko, A Beasley, et al.

Biochemistry|August 5, 2000

Histidine-607 and histidine-643 provide important interactions for metal support of catalysis in phosphodiesterase-5S H Francis, I V Turko, K A Grimes, et al.

Molecular Pharmacology|July 1, 1999

Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compoundsI V Turko, S A Ballard, S H Francis, et al.

The Journal of Biological Chemistry|September 6, 1996

Identification of key amino acids in a conserved cGMP-binding site of cGMP-binding phosphodiesterases. A putative NKXnD motif for cGMP bindingI V Turko, T L Haik, L M McAllister-Lucas, et al.

Cell Biochemistry and Biophysics|June 19, 1998

A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5)J D Corbin, A Beasley, I V Turko, et al.

International Journal of Clinical Practice|August 9, 2002

Pharmacology of phosphodiesterase-5 inhibitorsJ D Corbin, S H Francis

Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:

Pageof 14

The Biochemical Journal|March 7, 1998

Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylationI V Turko, S H Francis, J D Corbin

Biochemistry|May 2, 1998

Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivityI V Turko, S H Francis, J D Corbin

The Journal of Biological Chemistry|April 16, 1998

Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesteraseI V Turko, S H Francis, J D Corbin

Progress in Nucleic Acid Research and Molecular Biology|September 29, 2000

Cyclic nucleotide phosphodiesterases: relating structure and functionS H Francis, I V Turko, J D Corbin

European Journal of Biochemistry|April 28, 2000

Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activitiesJ D Corbin, I V Turko, A Beasley, et al.

Biochemistry|August 5, 2000

Histidine-607 and histidine-643 provide important interactions for metal support of catalysis in phosphodiesterase-5S H Francis, I V Turko, K A Grimes, et al.

Molecular Pharmacology|July 1, 1999

Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compoundsI V Turko, S A Ballard, S H Francis, et al.

The Journal of Biological Chemistry|September 6, 1996

Identification of key amino acids in a conserved cGMP-binding site of cGMP-binding phosphodiesterases. A putative NKXnD motif for cGMP bindingI V Turko, T L Haik, L M McAllister-Lucas, et al.

Cell Biochemistry and Biophysics|June 19, 1998

A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5)J D Corbin, A Beasley, I V Turko, et al.

International Journal of Clinical Practice|August 9, 2002

Pharmacology of phosphodiesterase-5 inhibitorsJ D Corbin, S H Francis

Pageof 14